genedrive (LON:GDR) Trading 10% Higher – Here’s Why

genedrive plc (LON:GDR)’s stock price traded up 10% during mid-day trading on Wednesday . The stock traded as high as GBX 0.88 and last traded at GBX 0.88. 4,591,832 shares were traded during trading, a decline of 76% from the average session volume of 18,979,752 shares. The stock had previously closed at GBX 0.80.

genedrive Stock Performance

The stock has a fifty day simple moving average of GBX 0.87 and a two-hundred day simple moving average of GBX 0.89. The company has a debt-to-equity ratio of 0.35, a quick ratio of 5.52 and a current ratio of 4.60. The stock has a market capitalization of £9.27 million, a price-to-earnings ratio of -0.42 and a beta of -0.04.

genedrive Company Profile

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.